Altimmune Plans Phase III MASH Trial Start in 2026 with Cash Runway to 2029
Summary: Altimmune, a biopharmaceutical company, announced plans to initiate the...
Sources on this story
Reported by 1 sources, including:
- Seeking Alpha
More AI-scored stories
- Minnesota man sentenced to life for assassinating Democratic lawmaker Melissa Hortman
- France Orders Evacuation of Cap Ferret Peninsula as Wildfires Spread
- UN human rights chief Volker Turk faces pushback in bid for second term
- Israeli Poll Shows Likud at Lowest Since June 2025, Eisenkot Surges
- Court rejects Trump administration's bid to re-detain pro-Palestinian activist
- Heavy localized rain in Kanto region; strict caution urged against flooding and rising river levels.
- France Releases Tanker Deliver Allegedly Linked to Russian 'Shadow Fleet'
- Germany Issues Security Advisory to Defense Firms After Russian List Publication